Skip to main content

Home/ Cerebral Palsy/ Group items tagged 17OHP

Rss Feed Group items tagged

1More

17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triple... - 0 views

  •  
    Hypothesis of study is that among women with twin or triplet pregnancies, weekly injections of 17-alpha-hydroxyprogesterone caproate (17OHP), started before 24 weeks of gestation, will reduce neonatal morbidity by reducing the rate of preterm delivery.This study involves two concurrent double-blinded randomized clinical trials of 17OHP versus placebo. Each trial will test the efficacy and safety of 17OHP in women with a specific risk factor for preterm birth. The two risk factors to be studied are: Twin pregnancy - Triplet pregnancy
1More

Progesterone (17OHP) for Prolongation of Pregnancy in Women With Preterm Rupture of the... - 0 views

  •  
    Study is to determine if a weekly dose of 17P (Progesterone) given to women with preterm rupture of the membranes will: increase the probability of continuing the pregnancy until a favorable gestational age.Increase the interval between randomization and delivery. Decrease neonatal morbidity.
1More

Progesterone (17OHP) for Prolongation of Pregnancy in Women With Preterm Rupture of the... - 0 views

  •  
    Planned study is to determine if a weekly dose of Progesterone (17OHP) given to women with preterm rupture of the membranes will: 1.increase the probability of continuing the pregnancy until a favorable gestational age. 2.increase the interval between randomization and delivery.3.decrease neonatal morbidity.
1 - 3 of 3
Showing 20 items per page